Sarepta Therapeutics | SRPT - 员工总数

金融业

USD

USD 3.35B

现金及等价物

USD 801.28M

USD 399.39M

USD 2.54B

USD 1.1B

USD 1.25B

USD -410.08M

USD -168.03M

1.37K

EPS每股收益

USD -3.58

股本和储备

USD 1.14B

USD 43.55M

债务利息支出

USD 7.56M

USD 8.38M

USD 828.97M

USD 1.56B

USD -412.23M

USD 853.02M

USD -410.08M

普通股股本

USD 104.96M

27.27

USD -407.68M

USD 442.9M

销售和管理费用

USD 105.38M

USD 914.74M

贸易债权人

USD 280.84M

应收帐款人

USD 398.23M

	员工	更改		日
Acadia Pharmaceuticals	653		56	2024-12
Agios Pharmaceuticals	486		103	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Amgen	28K		1.3K	2024-12
BioCryst Pharmaceuticals	536		5	2023-12
Biogen	7.6K		35	2024-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Capricor Therapeutics	101		27	2023-12
Daiichi Sankyo	19.76K		1.04K	2025-12
Eli Lilly	47K		4K	2024-12
Esperion Therapeutics	240		41	2023-12
Gilead Sciences	17.6K		400	2024-12
Incyte	2.62K		93	2024-12
Insmed	1.27K		359	2024-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Moderna	5.8K		200	2024-12
Nektar Therapeutics	137		79	2023-12
Neurocrine Biosciences	1.8K		400	2024-12
Novavax	1.54K		449	2023-12
Pfizer	81K		7K	2024-12
PTC Therapeutics	939		49	2024-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Roche Holding	103.61K		2.69K	2022-12
Sangamo BioSciences	405		73	2023-12
Sanofi	84.59K		3.41K	2024-12
Sarepta Therapeutics	1.37K		58	2024-12
Tectonic Therapeutic	45		1	2023-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vertex Pharmaceuticals	6.1K		700	2024-12